Preliminary experiments point out conolidine could inhibit distinct ion channels, lowering neuronal excitability and restricting discomfort alerts. This mechanism is particularly applicable in neuropathic suffering, in which irregular signaling causes persistent soreness. Also, conolidine appears to influence G protein-coupled receptor (GPCR) pathways integral to soreness perception. ... https://quentinz814dxr0.wikigop.com/user